Common use of Notice of Pharmaceutical Side-Effects Clause in Contracts

Notice of Pharmaceutical Side-Effects. During the term of this Agreement, the parties shall keep each other promptly and fully informed and will promptly notify appropriate authorities in accordance with applicable law, after receipt of information with respect to any serious adverse event (as defined by the ICH Harmonized Tripartite Guideline on Clinical Safety Data Management), directly or indirectly attributable to the use or application of Compounds, a Development Candidate, Bulk Drug Substance, a Drug Product Candidate, a Drug Product, and any other product for which royalties are payable under this Agreement.

Notice of Pharmaceutical Side-Effects. During the term of this Agreement, each of the parties shall keep each other promptly and fully informed and Parties will promptly notify appropriate authorities in accordance with applicable law, and the other Party, promptly after receipt of information with respect to any serious adverse event (as defined by the ICH Harmonized Tripartite Guideline on Clinical Safety Data Management), directly or indirectly attributable to the use or application of Compounds, a Development Candidate, Bulk Drug Substance, a Drug Product Candidate, the Compound or a Drug Product, and any other product for which royalties are payable under this Agreement.

Notice of Pharmaceutical Side-Effects. During the term of this Agreement, each of the parties shall keep each other promptly and fully informed and will promptly notify appropriate authorities in accordance with applicable law, and the other party, promptly after receipt of information with respect to any serious adverse event (reaction, as defined by the ICH Harmonized Tripartite Guideline on Clinical Safety Data Management)World Health Organization, directly or indirectly attributable to the use or application of Compounds, a Development Candidate, Bulk Drug Substance, a Drug Product Candidate, Candidate or a Drug Product, and any other product for which royalties are payable under this Agreement.

Notice of Pharmaceutical Side-Effects. During the term of this Agreement, the parties shall keep each other promptly and fully informed and will promptly notify appropriate authorities in accordance with applicable law, after receipt of information with respect to any serious adverse event (reaction, as defined by the ICH Harmonized Tripartite Guideline on Clinical Safety Data Management)World Health Organization, directly or indirectly attributable to the use or application of Compounds, a Development Candidate, Bulk Drug Substance, a Drug Product Candidate, Candidate or a Drug Product, and any other product for which royalties are payable under this Agreement.

Notice of Pharmaceutical Side-Effects. During the term of this Option Agreement, the parties shall keep each other promptly and fully informed and will promptly notify appropriate authorities in accordance with applicable law, after receipt of information with respect to any serious adverse event (reaction, as defined by the ICH Harmonized Tripartite Guideline on Clinical Safety Data Management)World Health Organization or applicable regulatory authority, directly or indirectly attributable to the use or application of Compounds, a Development Candidate, Bulk Drug Substance, a Drug Product Candidate, a Drug Product, . [Signature Page and any other product for which royalties are payable under Exhibits Follow] [*] Certain information on this Agreementpage has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.